ISIS-353512

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameISIS-353512
Drug Alias NameISIS-353512
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionC-reactive protein inhibitors
TargetsC-reactive protein
Therapy Area/IndicationsInflammationAtrial FibrillationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaRussian FederationUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationAtrial FibrillationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A